Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03589326
Title A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine + Methotrexate + Ponatinib

Dexamethasone + Ponatinib + Vincristine Sulfate

Ponatinib + Prednisone + Vincristine Sulfate

Dexamethasone + Imatinib + Vincristine Sulfate

Cytarabine + Imatinib + Methotrexate

Imatinib + Prednisone + Vincristine Sulfate

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN | AUT


No variant requirements are available.